Assessment of cardiovascular risk in shift healthcare workers

European Journal of Preventive Cardiology

Volumn 15, Issue 2, 2008, Pages 224-229

  Copertaro, Alfredo ^a   Bracci, Massimo ^b   Barbaresi, Mariella ^a   Santarelli, Lory ^b  

^a Regional Health Administration   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

cardiovascular diseases; hyperhomocysteinemia; metabolic syndrome; shift work

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH CARE PERSONNEL; HUMAN; HYPERHOMOCYSTEINEMIA; INCIDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SHIFT WORKER;

ADULT; AGED; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; FEMALE; HEALTH PERSONNEL; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OCCUPATIONAL DISEASES; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; WORK SCHEDULE TOLERANCE;

EID: 41949110634     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3282f364c0     Document Type: Article

References (23)

1. Schnall PL, Belkic K, Landbergis P, Baker D, editors. The workplace and cardiovasculardisease. Occup Med 2000; 15: 1–6.
2. Olsen O, Kristensen TS. Impact of work environment on cardiovascular disease inDenmark. J Epidemiol Commun Health 1991; 45: 4–9.
3. Boggild H, Knuttson A. Shift work. Risk factors and cardiovasculardisease. Scand J Work Environ Health 1999; 25: 85–89.
4. Karlsson B, Knutsson A, Lindahl B. Is there an association between shift work and having a metabolicsyndrome? Result from a population based study of 27485people. Occup Environ Med 2001; 58: 547–552.
5. Grundy SM. Metabolic syndrome: a multiplex cardiovascular riskfactor. J Clin Endocrinol Metab 2007; 92: 399–404.
6. DECODE Study Group. Does diagnosis of themetabolic syndrome detect further men at high risk of cardiovascular deathbeyond those identified by a conventional cardiovascular risk score? TheDECODE Study. Eur J Cardiovasc Prev Rehabil 2007; 14: 192–199.
7. Martins PJF, D'Almeida V, Vergani N, Perez ABA, Tufik S. Increased plasma homocysteine levels in shift working busdrivers. Occup Environ Med 2003; 60: 662–666.
8. National Institutes of Health. Third report of the national cholesterol education program expertpanel on detection, evaluation, and treatment of high blood cholesterolin adults (adult treatment panel III). Bethesda, Maryland: National Institutes of Health; NIHPublication 01–3670; 2001.
9. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. Themetabolic syndrome. A new worldwide definition. Lancet 2005; 366: 1059–1062.
10. Ferrario M, Chiodini P, Chambless LE, Cesana G, Vanuzzo D, Panico S, et al, CUORE Project Research Group. Prediction ofcoronary events in a low incidence population. Assessing accuracy of theCUORE Cohort Study prediction equation. Int J Epidemiol 2005; 34: 413–421.
11. Kohli P, Greenland P. Role of the metabolic syndrome in risk assessment for coronaryheart disease. JAMA 2006; 295: 819–821.
12. Herrmann M, Taban-Shomal O, Hubner U, Bohm M, Herrmann W. A review of homocysteine and heart failure. Eur J Heart Fail 2006; 8: 571–576.
13. SPREAD (Stroke Prevention And Educational Awareness Diffusion) Ictuscerebrale: linee guida italiane di prevenzione e trattamento. Pubblicazioni Catel-Hyperphar Group SpA IV Edizione. Milan. 2005.
14. Virtanen JK, Voutilainen S, Happonen P, Alfthan G, Kaikkonen J, Mursu J, et al Serum homocysteine, folate and risk of stroke: Kuopio IschaemicHeart Disease Risk Factor (KIHD) Study. Eur J Cardiovasc Prev Rehabil 2005; 12: 369–375.
15. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a factor forvascular disease. Protable benefits of increasing folic acidintakes. JAMA 1995; 274: 1049–1057.
16. Van Der Griend R, Biesma DH, Banga J-D. Hyperhomocysteinemia as a cardiovascular risk factor: anupdate. Nether J Med 2000; 56: 119–130.
17. Wald DS, Law M, Morris JK. The dose-response relation between serum homocysteine andcardiovascular disease: implications for treatment andscreening. Eur J Cardiovasc Prev Rehabil 2004; 11: 250–253.
18. McCully KS, Wilsons RB. Homocysteine theory of arteriosclerosis. Atherosclerosis 1975; 22: 215–227.
19. Abbate R, Sardi I, Pepe G, Marcucci R, Brunelli T, Prisco D, et al The high prevalence of thermolabile 5–10methylenetetrahydrofolatereductase (MTHFR) in Italians is not associated toan increased risk for coronary artery disease (CAD). Thromb Haemost 1997; 79: 727–730.
20. Lin JS, Shen MC, Cheng WC, Tsay W, Wang YC, Lin BB, Hung MH. Age, sex and vitamin status affect plasma level of homocysteine,but hyperhomocysteinaemia is possibly not an important risk factor forvenous thrombophilia in Taiwanese Chinese. Br J Haematol 2002; 117: 159–163.
21. Belkic K, Landsbergis P, Schnall P, Baker D. Is job strain a major source of cardiovascular disease risk? Scand J Work Environ Health 2004; 30: 85–128.
22. Cox T, Griffiths A, Rial-Gonzales E. Research on work-related stress. Luxemburg: EuropeanAgency of Safety and Health at Work. Office for Official Publications of theEuropean Communities; 2000.
23. Knuttson A, Boggild H. Shiftwork and cardiovascular disease: review of diseasemechanisms. Rev Environ Health 2000; 15: 559–572.